Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

Troy A Moore1, Robert W Buchanan, Peter F Buckley

  • 1Department of Psychiatry, The University of Texas Health Science Center at San Antonio, USA. mooret3@uthscsa.edu

The Journal of Clinical Psychiatry
|December 7, 2007
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scaling pediatric mental health care through primary care workforce training: a task-sharing and upskilling implementation strategy.

Implementation science communications·2026
Same author

Pediatric Mental Health Practice Change: A Scalable Model for Training and Evaluation.

Psychiatric services (Washington, D.C.)·2026
Same author

Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system.

Frontiers in psychiatry·2026
Same author

Do early intervention services for psychosis maintain their effects after transition to usual/modular care? A systematic review and meta-analysis.

World psychiatry : official journal of the World Psychiatric Association (WPA)·2026
Same author

Insomnia and substance use in psychotic disorders.

Schizophrenia research·2025
Same author

The PARCS Pilot Study Randomized Controlled Trial: Feasibility and Acceptability of a Park-Based Exercise Program Led by Peer Specialists for Peers with Serious Mental Illness.

Journal of healthy eating and active living·2025
Same journal

Major Depressive Disorder and PTSD Treatment Outcome in Interpersonal Psychotherapy and Prolonged Exposure.

The Journal of clinical psychiatry·2026
Same journal

Psychiatrists and Medical Aid in Dying: Entering Uncharted Waters.

The Journal of clinical psychiatry·2026
Same journal

Mind and Metabolism in Crisis: US Mortality Involving Obesity and Psychiatric Disorders-Trends, Disparities, and ARIMA Projections.

The Journal of clinical psychiatry·2026
Same journal

Generative AI for the Clinical Psychopharmacologist: Is It Ready for Prime Time?

The Journal of clinical psychiatry·2026
Same journal

Posttrauma Benzodiazepine Use and Subsequent PTSD: A Population-Wide Analysis Following Extreme Traumatic Exposure.

The Journal of clinical psychiatry·2026
Same journal

The Challenges of PTSD Prevention: Placing Benzodiazepine Use in Context.

The Journal of clinical psychiatry·2026
See all related articles
This summary is machine-generated.

Updated schizophrenia treatment guidelines recommend lower antipsychotic doses for first-episode patients and prefer second-generation antipsychotics. Clozapine use is advised after two trials, earlier if suicidality or substance abuse is present.

Area of Science:

  • Psychiatry
  • Pharmacology
  • Clinical Decision-Making

Background:

  • Consensus conference convened academic psychiatrists, pharmacists, clinicians, advocates, and consumers in June 2006.
  • Reviewed evidence on pharmacologic treatment of schizophrenia to update the Texas Medication Algorithm Project (TMAP) algorithm.
  • The TMAP algorithm is integral to the Texas Implementation of Medication Algorithms quality assurance program.

Framework:

  • Revised algorithm incorporates evidence on antipsychotic treatment for schizophrenia.
  • Key questions addressed first-episode vs. multi-episode treatment, role of first-generation antipsychotics (FGAs), clozapine trial sequencing, and augmentation strategies.
  • Recommendations provide a framework for clinical decision-making in schizophrenia pharmacotherapy.

Implementation:

Related Experiment Videos

  • First-episode schizophrenia treatment favors second-generation antipsychotics (SGAs) with lower doses and careful side effect monitoring.
  • FGAs are options in later algorithm stages alongside SGAs (excluding clozapine).
  • Two antipsychotic trials are recommended before clozapine, with earlier consideration for suicidality, comorbid violence, or substance abuse.

Implications:

  • Augmentation strategies for clozapine are considered reasonable but lack replicable positive results in published literature.
  • The updated algorithm aims to improve schizophrenia treatment quality assurance.
  • Clinical judgment remains paramount, and practices will evolve with new evidence and medications.